Thermo Fisher Scientific Inc. (TMO)

276.15
NYSE : Health Technology
Prev Close 273.31
Day Low/High 274.25 / 277.35
52 Wk Low/High 208.34 / 305.45
Avg Volume 1.43M
Exchange NYSE
Shares Outstanding 400.48M
Market Cap 109.45B
EPS 7.30
P/E Ratio 31.20
Div & Yield 0.76 (0.27%)

Latest News

Selected Earnings

United Parcel Service EPS: beat Revs: beat, +3.4% y/y Record profit across all segments Raised guidance   AT&T EPS: in line Revs: in line, +15.3% y/y Subscriber losses Raised guidance for free cash flow   General Dynamics EPS: beat Revs: beat, +4.0%...

Danaher Could Dip Near-Term, Providing a Buying Opportunity

Danaher Could Dip Near-Term, Providing a Buying Opportunity

DHR shares are up 35% in 2019.

Thermo Fisher Scientific Is Showing Us 3 Strong Charts

Thermo Fisher Scientific Is Showing Us 3 Strong Charts

Here's how to play the stock right now.

Netflix Taking a Knife to a Gunfight with Disney, Apple, Plus Bitcoin

Netflix Taking a Knife to a Gunfight with Disney, Apple, Plus Bitcoin

Bitcoin, the most famous of all crypto-currencies, has enjoyed something of a rebound of late.

Keep Your Eye on the Oncology Sector Among Biotech Stocks

Keep Your Eye on the Oncology Sector Among Biotech Stocks

The myriad names in oncology have been the hottest area for acquisitions along with gene therapy.

Why Huawei Matters, FOMC Decision, AAPL Results, Watching NOW: Market Recon

Why Huawei Matters, FOMC Decision, AAPL Results, Watching NOW: Market Recon

I think we can all agree that there will be no increase made to the Fed Funds Rate today.

Thermo Fisher Shows Super Relative Strength - Go Long or Add to Longs

Thermo Fisher Shows Super Relative Strength - Go Long or Add to Longs

Let's check the charts and indicators.

How to Trade Microsoft Into Earnings: Market Recon

How to Trade Microsoft Into Earnings: Market Recon

Add to longs near this key support level.

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

How to Play a Possible Breakout in Starbucks: Market Recon

How to Play a Possible Breakout in Starbucks: Market Recon

This options strategy on SBUX offers potential reward with little risk.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Jim Cramer: Follow the Bouncing Equities

Jim Cramer: Follow the Bouncing Equities

Markets start day with a bungee jump.

Uncertainty Is the New Market Normal -- And More Severe Tests Are Coming

Uncertainty Is the New Market Normal -- And More Severe Tests Are Coming

There is likely more headline risk to our front than to our rear.

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

Who, out there in the health care sector, is safe?

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.

Cramer: Lessons From the Market and ICR

Cramer: Lessons From the Market and ICR

You can make a case to buy any of the stocks of the companies at ICR.

Thermo Fisher Rated New Buy at BTIG

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

The Real Story Is Not Tax Reform; It Is Global Demand: Market Recon

The Real Story Is Not Tax Reform; It Is Global Demand: Market Recon

It looks like China is building again.

Cramer: Here Are the Ideal Stocks Now

Cramer: Here Are the Ideal Stocks Now

All the great stocks have artificial intelligence and e-commerce in common.

Jim Cramer: Agilent Technology Has Been One of My Favorites

Jim Cramer: Agilent Technology Has Been One of My Favorites

What's next for shares of Agilent Technology.

Cramer: Secondary Offerings Get Primary Attention

Cramer: Secondary Offerings Get Primary Attention

Thermo Fisher and McCormick deals show the true colors of stocks.

How to Get on Board Thermo Fisher Scientific

How to Get on Board Thermo Fisher Scientific

The stock could reach $200.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

Exxon, Thermo Fisher and 2 More Are Showing Red Flags

Exxon, Thermo Fisher and 2 More Are Showing Red Flags

These big stocks are teetering on the edge of breakdown territory.